Pittsburgh Life Sciences Company Using Community Health Surveillance Platform to Track H1N1 Flu (Swine Flu)
Posted on: Monday, 4 May 2009, 14:22 CDT
HMS provides federal, state, local and regional public health and health care organizations [with the means to collect and analyze admission data from hospital emergency rooms (ERs)] in various regions around
HMS is responding to the H1N1 Flu concern by working with public health officials to customize and increase the surveillance capabilities of the EpiCenter(TM) software service in the face of a pandemic. HMS Chief Technical Officer
HMS EpiCenter(TM) is currently providing real-time public health information by gathering data from 350 hospitals in 15 states - acting like a "forecaster" for the spread of disease. This includes service to some of the areas first hit by the H1N1 scare, including
"The public health professionals we serve are taking the outbreak of H1N1 very seriously and are working incredibly hard to understand what is happening and how it affects each of our communities," said
About Health Monitoring Systems (HMS)
HMS is helping detect, pinpoint and understand real-time and emerging health and safety issues on a local, regional, state and federal basis. Armed with up-to-date and reliable data about outbreaks and patterns of disease, crime and other health and safety developments, including possible bioterrorism, government health officials, hospital staff and pharmaceutical industry managers are empowered to act proactively in the protection of public health and safety. www.hmsinc.com
SOURCE Pittsburgh Life Sciences Greenhouse
Source: PR Newswire
Related Articles
- iJET Provides Additional Services in Response to Ongoing H1N1 Influenza A (Swine Flu) Developments
- BioMS Medical's phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
- BioMS Medical's Phase III U.S. Multiple Sclerosis Trial Receives Positive Safety Review From Data Safety Monitoring Board
- Stem Cell Therapeutics Corp. Receives Positive Review From Data Safety &Amp; Monitoring Board
- BioMS Medical's Phase III U.S. Multiple Sclerosis Trial Receives Positive Safety Review From Data Safety Monitoring Board
- Critical Therapeutics Announces the Publication of Data for ZYFLO CR(TM) (Zileuton) Extended-Release Tablets in the Journal of Asthma
- Bayer Pharmaceuticals Corporation Informs Health Care Professionals of Important Safety Revisions to the Trasylol Label
- International Health Ministers Commit Cooperation Against Bird Flu
- NetWellness Unveils Expanded African American Health Site at Congressional Black Caucus Health Braintrust Public Forum on Health Disparities at Case
- Mental Health Services: A Public Health Perspective, 2nd Ed.
User Comments (0)

RSS Feeds